When: Relief bounce into $259-265 (50 SMA at $264.52 acting as resistance)

Then: Execute ~10% conditional trim

When: Overshoot to $230-235 with confirmed capitulation print (RSI sub-30, bullish divergence on successive lower-lows, MACD histogram flattening, declining volume)

Then: Add back trimmed portion or scale larger for asymmetric payoff

Trim no more than 10-15% of the position, and only on a confirmed close above the 50-day SMA at $264.50 on volume. Do not pre-commit to selling into exhaustion at $248.

• MCD is a defensive cyclical franchise with Beta of 0.41, 46.5% operating margin, $7.19 billion in free cash flow, and a 2.99% dividend that has grown every year for decades
• RSI at 32.58 with the lower Bollinger Band just breached indicates selling into exhaustion rather than strength
• ATR is $4.36 and the stock has fallen from $334 to $248 over seven months, down 18% year to date—bad news is likely already priced in
• The aggressive three-tranche exit plan ($259, $270-275, $280) requires three separate relief bounces in sequence and leaves limit orders hanging above current price that may never fill
• Forward P/E of 17.8x with a 3% yield makes this a compelling hold for patient capital accumulation
• Bloomberg editorial framing is not a valuation model; actual Beta of 0.41 defines MCD as defensive by construction
• If price makes a new low below $245 with expanding volume, that is the legitimate technical breakdown signal to re-evaluate—not the current level

→ vs aggressive: The three-tranche exit plan requires three separate relief bounces in sequence—a hope dressed as a strategy, not a plan. If the bear case is dominant, any bounce is more likely to be rejected at the 50-day SMA around $264 and the staircase collapses.

→ vs aggressive: The 'direction without magnitude' thesis is catastrophic in practice for a 0.41 Beta Dividend Aristocrat. Selling based on four weeks of bad price action means exiting just as patient capital is accumulating, then watching the dividend bid reabsorb the loss.

→ vs aggressive: Macro risks (84% Polymarket odds, $100 oil, FOMC decision) are already in the price at $248—selling now treats a falling knife as if the descent will be monotonic when it almost never is.

→ vs aggressive: Bloomberg's editorial grouping with Walmart and Nike is a journalist's headline, not a valuation model. MCD's actual Beta of 0.41 defines it as defensive by construction, not by narrative.

→ vs aggressive: The 'confirmation prints after the low' reasoning is hindsight-friendly but the aggressive analyst wants action now, not waiting for actual confirmation—if the reclaim at $264 fails and the stock makes a new low, that is the legitimate signal.

Trim 15-20% of position via staged exit: 5-7% now near lower Bollinger Band, remaining trim at 259 and 270 resistance levels on relief bounce, with closing-basis stop at 240 and explicit re-engagement plan at 230-235

• Aggressive analyst's three-tranche scaled exit plan (10% at 259-265, 10% at 270-275, 10% above 280) is structurally weak because 50-day SMA at 264.52 will likely act as resistance, not support
• MCD Beta of 0.41 means magnitude matters—bear case could reach 240, but relief rally could be 8-12% in a single session
• CEO reframing was already priced in as stock dropped from 334 to 248 before public admission
• Conservative analyst's 'bad news is priced' argument is unfalsifiable and appears at every major low
• Conservative analyst's trim trigger at 264.50 requires 6% rally from current levels—that's a confirmed reversal, not a trim signal
• Operating margin (46.5%) and dividend yield (3%) don't prevent capital losses from multiple compression (20x to 16x = 20% loss)
• Bloomberg sectoral framing creates mechanical flows via pension funds, ETFs, and retail screens that cannot be dismissed
• Optimal trim size is 15-20% to preserve 80%+ participation in relief rally while reducing directional risk
• Intraday stop at 259 is too tight given ATR of 4.36 and probability of oversold bounce being pierced before reversal
• Explicit re-engagement criteria at 230-235 creates asymmetric payoff if capitulation occurs, which is more disciplined than aggressive analyst's plan

→ vs aggressive: Three-tranche exit plan above current price is structurally flawed; 50-day SMA at 264.52 will likely reject price, leaving only one tranche filled at mediocre average

→ vs aggressive: Beta of 0.41 means magnitude matters; trimming 30% on uncertain downside gives up reversion premium that could be 8-12% on any relief

→ vs aggressive: CEO reframing was already priced in before public admission; treating confirmation as fresh catalyst is analytical error

→ vs conservative: 'Bad news is priced' is unfalsifiable and appears at every major market low; technicals show lower highs, accelerating MACD negative, death cross imminent

→ vs conservative: Trim trigger at 264.50 requires 6% rally from current levels, which is a fully validated reversal signal, not a trim trigger

→ vs conservative: Quality floor (46.5% operating margin, 3% dividend) doesn't prevent 20% capital loss if multiple compresses from 20x to 16x

→ vs conservative: Dismissal of Bloomberg framing ignores mechanical flows from pension funds, ETFs, and retail screens that reallocate on sectoral classifications